Recruiting OBSERVATIONAL NCT04055571

Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases

Sponsor: Methodist Health System

Conditions Benign or Malignant Pancreatic Diseases

Updated 8 times since 2019 Last updated: Mar 26, 2024 Started: Mar 5, 2019 Primary completion: Jan 30, 2025 Completion: Jan 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Benign or Malignant Pancreatic Diseases and is currently actively recruiting participants. Methodist Health System leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting
Mar 2022 — Apr 2024 [monthly]

Recruiting
Jan 2021 — Mar 2022 [monthly]

Recruiting

▶ Show 3 earlier versions

Dec 2020 — Jan 2021 [monthly]

Recruiting
Feb 2020 — Dec 2020 [monthly]

Recruiting
Sep 2019 — Feb 2020 [monthly]

Recruiting

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Methodist Health System

Data source: Methodist Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Richardson, United States